These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 2672607)

  • 1. [Future prospects for the use of tumor markers].
    Grunicke H
    Wien Klin Wochenschr; 1989 Jul; 101(14):472-5. PubMed ID: 2672607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Growth factors as biological markers of malignancy].
    Tahara E; Yokozaki H
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1102-8. PubMed ID: 3260465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncogenes and oncoproteins as tumor markers.
    Pillai R
    Eur J Surg Oncol; 1992 Oct; 18(5):417-24. PubMed ID: 1426290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The potential of oncogene products as tumour markers.
    Chan S; Sikora K
    Cancer Surv; 1987; 6(2):185-207. PubMed ID: 3322544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of the biologic markers of breast cancer.
    Porter-Jordan K; Lippman ME
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):73-100. PubMed ID: 8150784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour markers.
    Pandha HS; Waxman J
    QJM; 1995 Apr; 88(4):233-41. PubMed ID: 7540924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tumor markers. Their current diagnostic status].
    Kudlacek S
    Wien Med Wochenschr; 1988 May; 138(10):228-42. PubMed ID: 3043919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardization of immunobioassays as surrogate endpoints.
    Masood S
    J Cell Biochem Suppl; 1994; 19():28-35. PubMed ID: 7823602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumour necrosis factor-alpha and transforming growth factor-beta are significantly associated with better prognosis in non-small cell lung carcinoma: putative relation with BCL-2-mediated neovascularization.
    Boldrini L; Calcinai A; Samaritani E; Pistolesi F; Mussi A; Lucchi M; Angeletti CA; Basolo F; Fontanini G
    Br J Cancer; 2000 Aug; 83(4):480-6. PubMed ID: 10945495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogenes, tumour suppressor genes and growth factors in breast cancer: novel targets for diagnosis, prognosis and therapy.
    Callahan R; Salomon DS
    Cancer Surv; 1993; 18():35-56. PubMed ID: 8012999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth factors and cancer.
    Goustin AS; Leof EB; Shipley GD; Moses HL
    Cancer Res; 1986 Mar; 46(3):1015-29. PubMed ID: 3002607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunophenotype, ras oncogenes and p53 onco-suppressor gene in benzo(a)pyrene induced malignant soft tissue tumours in Wistar rats.
    Stefanou DG; Nonni AV; Kalpouzos G; Evangelou A; Agnantis NJ
    In Vivo; 1998; 12(5):511-21. PubMed ID: 9827359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of circulating tumor markers: from enzyme, carcinoembryonic protein to oncogene and suppressor gene.
    Wu JT
    Ann Clin Lab Sci; 1999; 29(2):106-11. PubMed ID: 10219697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Tumor marker analyses--valuable tools if used correctly].
    Børmer OP; Paus E; Nustad K; Theodorsen L
    Tidsskr Nor Laegeforen; 1994 Nov; 114(28):3317-20. PubMed ID: 7809890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and predictive molecular markers in colorectal carcinoma.
    Bendardaf R; Lamlum H; Pyrhönen S
    Anticancer Res; 2004; 24(4):2519-30. PubMed ID: 15330208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.